Literature DB >> 30382555

S100 proteins as therapeutic targets.

Anne R Bresnick1.   

Abstract

The human genome codes for 21 S100 protein family members, which exhibit cell- and tissue-specific expression patterns. Despite sharing a high degree of sequence and structural similarity, the S100 proteins bind a diverse range of protein targets and contribute to a broad array of intracellular and extracellular functions. Consequently, the S100 proteins regulate multiple cellular processes such as proliferation, migration and/or invasion, and differentiation, and play important roles in a variety of cancers, autoimmune diseases, and chronic inflammatory disorders. This review focuses on the development of S100 neutralizing antibodies and small molecule inhibitors and their potential therapeutic use in controlling disease progression and severity.

Entities:  

Keywords:  Calcium binding; Neutralizing antibody; S100 protein; Small molecule inhibitor

Year:  2018        PMID: 30382555      PMCID: PMC6297089          DOI: 10.1007/s12551-018-0471-y

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  24 in total

1.  Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.

Authors:  Gu Xiao; George K Annor; Kimberly Fung; Outi Keinänen; Brian M Zeglis; Jill Bargonetti
Journal:  Mol Pharm       Date:  2020-12-08       Impact factor: 4.939

Review 2.  Toll-like receptors and damage-associated molecular patterns in the pathogenesis of heart transplant rejection.

Authors:  Alice Kesler; Devendra K Agrawal; Finosh G Thankam
Journal:  Mol Cell Biochem       Date:  2022-06-09       Impact factor: 3.396

3.  Calcium-Bound S100P Protein Is a Promiscuous Binding Partner of the Four-Helical Cytokines.

Authors:  Alexey S Kazakov; Evgenia I Deryusheva; Maria E Permyakova; Andrey S Sokolov; Victoria A Rastrygina; Vladimir N Uversky; Eugene A Permyakov; Sergei E Permyakov
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

Review 4.  Emerging role of S100B protein implication in Parkinson's disease pathogenesis.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

5.  A Clinicopathological Analysis of S100A14 Expression in Colorectal Cancer.

Authors:  Angela Diamantopoulou; Dimitrios Mantas; Ioannis D Kostakis; George Agrogiannis; Zoe Garoufalia; Nikolaos Kavantzas; Gregory Kouraklis
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

6.  Erythropoietin Interacts with Specific S100 Proteins.

Authors:  Alexey S Kazakov; Evgenia I Deryusheva; Andrey S Sokolov; Maria E Permyakova; Ekaterina A Litus; Victoria A Rastrygina; Vladimir N Uversky; Eugene A Permyakov; Sergei E Permyakov
Journal:  Biomolecules       Date:  2022-01-12

7.  Proteins and Molecular Pathways Relevant for the Malignant Properties of Tumor-Initiating Pancreatic Cancer Cells.

Authors:  Lisa Samonig; Andrea Loipetzberger; Constantin Blöchl; Marc Rurik; Oliver Kohlbacher; Fritz Aberger; Christian G Huber
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

8.  Morphological and immunohistochemical phenotype of TCs in the intestinal bulb of Grass carp and their potential role in intestinal immunity.

Authors:  Hanan H Abd-Elhafeez; Alaa S Abou-Elhamd; Soha A Soliman
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

9.  S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.

Authors:  Lingzhi Wang; Wei Yan; Xukun Li; Zhihua Liu; Tian Tian; Tanxiu Chen; Liang Zou; Zhumei Cui
Journal:  J Ovarian Res       Date:  2019-11-18       Impact factor: 4.234

10.  S100 Calcium Binding Protein A10, A Novel Oncogene, Promotes the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma.

Authors:  Xing Zhou; Min Shi; Jun Cao; Tianwen Yuan; Guanzhen Yu; Ying Chen; Wenzheng Fang; Hongwei Li
Journal:  Front Genet       Date:  2021-06-11       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.